We are live on ! Find out more
CINC

CinCor Pharma, Inc. Common Stock
CINC

Delisted

CINC was delisted on the 23rd of February, 2023.

Back to rankings

53 hedge funds and large institutions have $520M invested in CinCor Pharma, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 53 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
53
Holders Change
+53
Holders Change %
–
% of All Funds
0.84%
Holding in Top 10
5
Holding in Top 10 Change
+5
Holding in Top 10 Change %
% of All Funds
0.08%
New
53
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SI
Sofinnova Investments
California
+$114M
2
5VM
5AM Venture Management
California
+$89M
3
GA
General Atlantic
New York
+$84.7M
4
PA
Perceptive Advisors
New York
+$47.6M
5
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$42.9M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
SI
1
Sofinnova Investments
California
$97.8M +$114M +5,573,949 New
5VM
2
5AM Venture Management
California
$76.1M +$89M +4,337,646 New
GA
3
General Atlantic
New York
$72.4M +$84.7M +4,126,470 New
PA
4
Perceptive Advisors
New York
$40.7M +$47.6M +2,319,117 New
Adage Capital Partners
5
Adage Capital Partners
Massachusetts
$36.6M +$42.9M +2,089,013 New
VP
6
venBio Partners
California
$34.7M +$40.6M +1,980,706 New
BI
7
BVF Inc
California
$30.4M +$35.6M +1,735,293 New
RI
8
RTW Investments
New York
$24.4M +$28.5M +1,389,705 New
RSCM
9
Rock Springs Capital Management
Maryland
$18.1M +$21.2M +1,031,159 New
OFM
10
Omega Fund Management
Massachusetts
$16.9M +$19.8M +966,176 New
SCV
11
Sands Capital Ventures
Virginia
$16.7M +$19.5M +950,000 New
T. Rowe Price Associates
12
T. Rowe Price Associates
Maryland
$12.6M +$14.8M +718,875 New
BlackRock
13
BlackRock
New York
$11.9M +$13.9M +676,010 New
Vanguard Group
14
Vanguard Group
Pennsylvania
$10.9M +$12.7M +619,284 New
Geode Capital Management
15
Geode Capital Management
Massachusetts
$3.66M +$4.29M +208,898 New
State Street
16
State Street
Massachusetts
$2.17M +$2.54M +124,009 New
Northern Trust
17
Northern Trust
Illinois
$1.75M +$2.04M +99,597 New
Charles Schwab
18
Charles Schwab
California
$1.56M +$1.82M +88,887 New
Fidelity Investments
19
Fidelity Investments
Massachusetts
$1.44M +$1.69M +82,169 New
GPP
20
Great Point Partners
Connecticut
$1.4M +$1.63M +79,670 New
CCM
21
CAAS Capital Management
New York
$1.32M +$1.54M +75,000 New
TD Asset Management
22
TD Asset Management
Ontario, Canada
$911K +$1.07M +51,965 New
D.E. Shaw & Co
23
D.E. Shaw & Co
New York
$613K +$717K +34,956 New
Manulife (Manufacturers Life Insurance)
24
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$568K +$626K +30,504 New
Bank of New York Mellon
25
Bank of New York Mellon
New York
$565K +$661K +32,210 New
1
2 3

CINC Hedge Fund Activity: Q1 2022 in Review

53 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in CinCor Pharma, Inc. Common Stock (CINC) for Q1 2022, worth a combined $520M.

Buyers outnumbered sellers: 53 funds opened new CINC positions and 0 closed out — a net gain of 53 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Sofinnova Investments, opening a new position worth an estimated $114M.

  • 53 institutional investors held CinCor Pharma, Inc. Common Stock (CINC) as of Q1 2022, up from 0 in Q4 2021.
  • Funds reported $520M of CinCor Pharma, Inc. Common Stock stock for Q1 2022.
  • 53 funds opened new CinCor Pharma, Inc. Common Stock positions in Q1 2022 and 0 closed out, a net change of +53 holders.
  • The largest CinCor Pharma, Inc. Common Stock buyer in Q1 2022 was Sofinnova Investments, an estimated $114M added.

Based on aggregated 13F filings for Q1 2022.